285 related articles for article (PubMed ID: 33298014)
1. Gene expression analysis of human prostate cell lines with and without tumor metastasis suppressor CD82.
Dodla P; Bhoopalan V; Khoo SK; Miranti C; Sridhar S
BMC Cancer; 2020 Dec; 20(1):1211. PubMed ID: 33298014
[TBL] [Abstract][Full Text] [Related]
2. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
Zeng TD; Zheng B; Zheng W; Chen C
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.
Desai B; Rogers MJ; Chellaiah MA
Mol Cancer; 2007 Mar; 6():18. PubMed ID: 17343740
[TBL] [Abstract][Full Text] [Related]
4. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
Zhou B; Liu L; Reddivari M; Zhang XA
Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
[TBL] [Abstract][Full Text] [Related]
5. KAI1/CD82, a tumor metastasis suppressor.
Liu WM; Zhang XA
Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
[TBL] [Abstract][Full Text] [Related]
6. KAI1/CD82, Metastasis Suppressor Gene as a Therapeutic Target for Non-Small-Cell Lung Carcinoma.
Prabhu VV; Devaraj SN
J Environ Pathol Toxicol Oncol; 2017; 36(3):269-275. PubMed ID: 29283339
[TBL] [Abstract][Full Text] [Related]
7. [Expression of tumor metastasis suppressor gene KAI1/CD82 in human cancer cell lines with different metastasis potential].
Li S; Fang W; Zhong H
Zhonghua Yi Xue Za Zhi; 1999 Sep; 79(9):708-10. PubMed ID: 11715465
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines.
Kim YI; Shin MK; Lee JW; Chung JH; Lee MH
Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457
[TBL] [Abstract][Full Text] [Related]
9. Metastasis suppressor KAI1/CD82 attenuates the matrix adhesion of human prostate cancer cells by suppressing fibronectin expression and β1 integrin activation.
Lee HA; Park I; Byun HJ; Jeoung D; Kim YM; Lee H
Cell Physiol Biochem; 2011; 27(5):575-86. PubMed ID: 21691075
[TBL] [Abstract][Full Text] [Related]
10. The metastasis suppressor CD82/KAI1 inhibits fibronectin adhesion-induced epithelial-to-mesenchymal transition in prostate cancer cells by repressing the associated integrin signaling.
Lee J; Byun HJ; Lee MS; Jin YJ; Jeoung D; Kim YM; Lee H
Oncotarget; 2017 Jan; 8(1):1641-1654. PubMed ID: 27926483
[TBL] [Abstract][Full Text] [Related]
11. Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines.
Sigala S; Faraoni I; Botticini D; Paez-Pereda M; Missale C; Bonmassar E; Spano P
Clin Cancer Res; 1999 May; 5(5):1211-8. PubMed ID: 10353759
[TBL] [Abstract][Full Text] [Related]
12. Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases.
Sridhar SC; Miranti CK
Oncogene; 2006 Apr; 25(16):2367-78. PubMed ID: 16331263
[TBL] [Abstract][Full Text] [Related]
13. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
Chakrabarti R; Robles LD; Gibson J; Muroski M
Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
[TBL] [Abstract][Full Text] [Related]
14. KAI1 suppresses HIF-1α and VEGF expression by blocking CDCP1-enhanced Src activation in prostate cancer.
Park JJ; Jin YB; Lee YJ; Lee JS; Lee YS; Ko YG; Lee M
BMC Cancer; 2012 Mar; 12():81. PubMed ID: 22390300
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
Sekita N; Suzuki H; Ichikawa T; Kito H; Akakura K; Igarashi T; Nakayama T; Watanabe M; Shiraishi T; Toyota M; Yoshie O; Ito H
Jpn J Cancer Res; 2001 Sep; 92(9):947-51. PubMed ID: 11572762
[TBL] [Abstract][Full Text] [Related]
16. Normal viability of Kai1/Cd82 deficient mice.
Risinger JI; Custer M; Feigenbaum L; Simpson RM; Hoover SB; Webster JD; Chandramouli GV; Tessarollo L; Barrett JC
Mol Carcinog; 2014 Aug; 53(8):610-24. PubMed ID: 23401136
[TBL] [Abstract][Full Text] [Related]
17. The metastasis suppressor CD82/KAI1 represses the TGF-β
Lee MS; Lee J; Kim YM; Lee H
Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
[TBL] [Abstract][Full Text] [Related]
18. KAI-1/CD82, the molecule and clinical implication in cancer and cancer metastasis.
Malik FA; Sanders AJ; Jiang WG
Histol Histopathol; 2009 Apr; 24(4):519-30. PubMed ID: 19224455
[TBL] [Abstract][Full Text] [Related]
19. Tetraspanin CD82 affects migration, attachment and invasion of rheumatoid arthritis synovial fibroblasts.
Neumann E; Schwarz MC; Hasseli R; Hülser ML; Classen S; Sauerbier M; Rehart S; Mueller-Ladner U
Ann Rheum Dis; 2018 Nov; 77(11):1619-1626. PubMed ID: 29980577
[TBL] [Abstract][Full Text] [Related]
20. KAI1/CD82 decreases Rac1 expression and cell proliferation through PI3K/Akt/mTOR pathway in H1299 lung carcinoma cells.
Choi UJ; Jee BK; Lim Y; Lee KH
Cell Biochem Funct; 2009 Jan; 27(1):40-7. PubMed ID: 19107873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]